Charles A. McWherter
2015
In 2015, Charles A. McWherter earned a total compensation of $1.1M as Senior Vice President and Chief Scientific Officer at Cymabay Therapeutics.
Compensation breakdown
| Bonus | $61,825 |
|---|---|
| Option Awards | $688,860 |
| Salary | $353,290 |
| Other | $20,266 |
| Total | $1,124,241 |
McWherter received $688.9K in option awards, accounting for 61% of the total pay in 2015.
McWherter also received $61.8K in bonus, $353.3K in salary and $20.3K in other compensation.
Rankings
In 2015, Charles A. McWherter's compensation ranked 7,375th out of 13,638 executives tracked by ExecPay. In other words, McWherter earned more than 45.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,375 out of 13,638 | 46th |
Division Manufacturing | 2,778 out of 5,190 | 47th |
Major group Chemicals And Allied Products | 1,001 out of 1,854 | 46th |
Industry group Drugs | 806 out of 1,528 | 47th |
Industry Pharmaceutical Preparations | 632 out of 1,182 | 47th |
Source: SEC filing on April 19, 2017.
McWherter's colleagues
We found two more compensation records of executives who worked with Charles A. McWherter at Cymabay Therapeutics in 2015.
News
Cymabay Therapeutics CEO Sujal Shah's 2022 pay rises 16% to $2.6M
April 19, 2023
Cymabay Therapeutics CEO Sujal Shah's 2021 pay slips 16% to $2.2M
April 26, 2022
Cymabay Therapeutics CEO Sujal Shah's 2019 pay jumps 32% to $2.6M
May 15, 2020
Cymabay Therapeutics General Counsel Paul Quinlan receives $3M in 2018
April 26, 2019